AI-designed anti-aging drug Rentosertib shows human data with six aging clocks pointing younger
rand_longevity · x · 2026-09-09
Rentosertib, an anti-aging drug candidate whose target selection and molecular design were done by AI, has reported human trial data.
- Both target identification and drug design were AI-driven
- Human data reportedly shows six aging clocks trending younger
- The poster highlights it as an exciting milestone for AI in science, marking AI-designed drugs reaching human efficacy evidence
Related event: AI-Designed IPF Drug Rentosertib Shows Biological Age Reversal in Trial(18 posts)→
More from Venture
- SendCutSend, born from a $750K impulse laser cutter buy, hits $2.1B valuation — kyliebytes · 2026-10-27
- After 20 Years of Launches, HN Shah Publishes His Early Access Playbook — AI_Andrew · 2026-10-27
- Cloudflare pilots Mastercard's Agent Payment for Machines with Coinbase wallets — kleffew94 · 2026-10-27
- Permissions are the moat: LetterBox wins Threads posting approval from Meta — rchardkovacs · 2026-10-27
- Anthropic hits $16.3B H1 revenue as compute efficiency jumps 5.2x in 18 months — daniel_mac8 · 2026-10-27
- YC-backed Hopper launches voice-agent inference cloud: 80 ms TTFT at $0.30/1M tokens — ycombinator · 2026-10-27